BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1686352)

  • 1. A dual anti-tumor effect of a combination of interferon-alpha and 5-flurouracil or 2-chlorodeoxyadenosine on natural killer (NK) cell mediated cytotoxicity.
    Reiter Z; Ozes ON; Tomson S; Blatt LM; Taylor MW
    Adv Exp Med Biol; 1991; 309A():69-73. PubMed ID: 1686352
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
    Reiter Z; Tomson S; Ozes ON; Taylor MW
    Blood; 1993 Apr; 81(7):1699-708. PubMed ID: 8096405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual anti-tumor effect of a combination of interferon-alpha or interleukin-2 and 5-fluorouracil on natural killer (NK) cell-mediated cytotoxicity.
    Reiter Z; Ozes ON; Blatt LM; Taylor MW
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):103-11. PubMed ID: 1370257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis induction with purine analogs on freshly isolated chronic myeloid leukemia cells.
    Zinzani PL; Martinelli G; Buzzi M; Farabegoli P; Bendandi M; Tura S
    Haematologica; 1995; 80(4):390-1. PubMed ID: 7590510
    [No Abstract]   [Full Text] [Related]  

  • 5. A possible role for interferon-alpha and activated natural killer cells in remission of AIDS-related Kaposi's sarcoma: in vitro studies.
    Reiter Z; Ozés ON; Blatt LM; Sturzl M; Taylor MW
    J Acquir Immune Defic Syndr (1988); 1992; 5(5):469-76. PubMed ID: 1560343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Chlorodeoxyadenosine chemotherapy triggers programmed cell death in normal and malignant lymphocytes.
    Carrera CJ; Piro LD; Saven A; Beutler E; Terai C; Carson DA
    Adv Exp Med Biol; 1991; 309A():15-8. PubMed ID: 1686349
    [No Abstract]   [Full Text] [Related]  

  • 7. 2-chlorodeoxyadenosine (2-CdA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cells.
    Gora-Tybor J; Lech-Miranda E; Blonski JZ; Robak T
    Adv Exp Med Biol; 2000; 486():307-10. PubMed ID: 11783506
    [No Abstract]   [Full Text] [Related]  

  • 8. Hairy-cells are not lysed by NK-cells.
    Sigaux F; Chapuis F; Castaigne S; Degos L; Flandrin G; Gluckman JC
    Blut; 1987 May; 54(5):319-20. PubMed ID: 3567370
    [No Abstract]   [Full Text] [Related]  

  • 9. Hairy cell leukemia cells are relatively NK-insensitive targets.
    Starling GC; Nimmo JC; Hart DN
    Pathology; 1988 Oct; 20(4):361-5. PubMed ID: 2977221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-interferon and lymphokine-activated killer cells in hairy cell leukemia.
    Griffiths SD; Cawley JC
    Leukemia; 1988 Jun; 2(6):377-81. PubMed ID: 3374170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural killer cell response to interferons.
    Abbud-Filho M; Ransil BJ; Kelley VE; Fiers W; Strom TB
    Clin Immunol Immunopathol; 1986 May; 39(2):264-76. PubMed ID: 3084143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant effect of interferon on natural killer activity and tumor cell sensitivity to lysis in hairy cell leukemia.
    Lahat N; Aghai E; Kotler A; Kinarty A; Sobel E; Gruener N; Froom P
    Blood; 1988 Apr; 71(4):1141-3. PubMed ID: 3258536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant interferon alpha 2 stimulation of target-binding by natural killer cells.
    Heidemann E; Weber J; Schmidt H; Reichmann U
    Klin Wochenschr; 1986 Oct; 64(20):1036-40. PubMed ID: 3465970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia.
    Bigda J; Mysliwska J; Dziadziuszko R; Bigda J; Mysliwski A; Hellmann A
    Leuk Lymphoma; 1993 May; 10(1-2):121-5. PubMed ID: 8104069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.
    Cheson BD
    Oncology (Williston Park); 1992 May; 6(5):95-8. PubMed ID: 1350917
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.
    Zinzani PL; Pellegrini C; Stefoni V; Derenzini E; Gandolfi L; Broccoli A; Argnani L; Quirini F; Pileri S; Baccarani M
    Cancer; 2010 Oct; 116(20):4788-92. PubMed ID: 20597132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
    Griffiths SD; Cawley JC
    Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
    Piro LD; Carrera CJ; Carson DA; Beutler E
    N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.